{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:06:50Z","timestamp":1791176810466,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T00:00:00Z","timestamp":1225411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0003597","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T18:10:36Z","timestamp":1225390236000},"page":"e3597","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Raft-Dependent Endocytosis of Autocrine Motility Factor\/Phosphoglucose Isomerase: A Potential Drug Delivery Route for Tumor Cells"],"prefix":"10.1371","volume":"3","author":[{"given":"Liliana D.","family":"Kojic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam M.","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Ghaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinyu","family":"Nedev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Uri","family":"Saragovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan R.","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.addr.2007.06.008","article-title":"Endocytic mechanisms for targeted drug delivery.","volume":"59","author":"LM Bareford","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2006.02.007","article-title":"Virus entry: open sesame.","volume":"124","author":"M Marsh","year":"2006","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbamcr.2005.06.002","article-title":"Clathrin-independent endocytosis: New insights into caveolae and non-caveolar lipid raft carriers.","volume":"1745","author":"M Kirkham","year":"2005","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1582-4934.2007.00083.x","article-title":"Regulation of raft-dependent endocytosis.","volume":"11","author":"P Lajoie","year":"2007","journal-title":"J Cell Mol Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"L823","DOI":"10.1152\/ajplung.00436.2006","article-title":"Molecular determinants of endothelial transcytosis and their role in endothelial permeability.","volume":"293","author":"SA Predescu","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers.","volume":"314","author":"T Sjoblom","year":"2006","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14737140.8.2.207","article-title":"Autocrine motility factor receptor: a clinical review.","volume":"8","author":"CG Chiu","year":"2008","journal-title":"Expert review of anticancer therapy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.129.2.459","article-title":"Autocrine motility factor receptor is a marker for a distinct tubular membrane organelle.","volume":"129","author":"N Benlimame","year":"1995","journal-title":"J Cell Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1242\/jcs.03486","article-title":"Reversible interactions between smooth domains of the endoplasmic reticulum and mitochondria are regulated by physiological cytosolic calcium levels.","volume":"120","author":"JG Goetz","year":"2007","journal-title":"J Cell Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1083\/jcb.150.6.1489","article-title":"Calcium regulates the association between mitochondria and a smooth subdomain of the endoplasmic reticulum.","volume":"150","author":"H-J Wang","year":"2000","journal-title":"J Cell Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1042\/BST0340370","article-title":"Interaction of the smooth endoplasmic reticulum and mitochondria.","volume":"340","author":"JG Goetz","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/nm1686","article-title":"The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation.","volume":"13","author":"YC Tsai","year":"2007","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.3020690","article-title":"Neuroleukin: A lymphokine product of lectin-stimulated T cells.","volume":"234","author":"ME Gurney","year":"1986","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1083\/jcb.102.6.2264","article-title":"Suppression of terminal axonal sprouting at the neuromuscular junction by monoclonal antibodies against a muscle-derived antigen of 56,000 daltons.","volume":"102","author":"ME Gurney","year":"1986","journal-title":"J Cell Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/332454a0","article-title":"The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase.","volume":"332","author":"M Chaput","year":"1988","journal-title":"Nature (Lond)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/332455a0","article-title":"Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3\u2032 sequences.","volume":"332","author":"P Faik","year":"1988","journal-title":"Nature (Lond)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1182\/blood.V87.11.4502.bloodjournal87114502","article-title":"The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase.","volume":"87","author":"W Xu","year":"1996","journal-title":"Blood"},{"key":"ref18","first-page":"2960","article-title":"Tumor cell autocrine motility factor is the neuroleukin\/phosphohexose isomerase polypeptide.","volume":"56","author":"H Watanabe","year":"1996","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1073\/pnas.83.10.3302","article-title":"Tumor cell autocrine motility factor.","volume":"83","author":"LA Liotta","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref20","first-page":"2667","article-title":"Expression and secretion of neuroleukin\/phosphohexose isomerase\/maturation factor as autocrine motility factor by tumor cells.","volume":"58","author":"Y Niinaka","year":"1998","journal-title":"Cancer Res"},{"key":"ref21","first-page":"1649","article-title":"Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.","volume":"148","author":"S Silletti","year":"1996","journal-title":"Am J Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1158\/1078-0432.CCR-04-1015","article-title":"Autocrine motility factor signaling enhances pancreatic cancer metastasis.","volume":"10","author":"S Tsutsumi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0167-4889(94)90046-9","article-title":"Effects of protein kinase inhibitors on the cell motility stimulated by autocrine motility factor.","volume":"1222","author":"K Kanbe","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"ref24","first-page":"4484","article-title":"Activation of small GTPase Rho is required for autocrine motility factor signaling.","volume":"62","author":"S Tsutsumi","year":"2002","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/labinvest.3700057","article-title":"Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta.","volume":"84","author":"T Yanagawa","year":"2004","journal-title":"Lab Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ijc.11449","article-title":"Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression.","volume":"107","author":"A Haga","year":"2003","journal-title":"Int J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/bbrc.2001.5135","article-title":"Tumor Autocrine Motility Factor Is an Angiogenic Factor That Stimulates Endothelial Cell Motility.","volume":"285","author":"T Funasaka","year":"2001","journal-title":"Biochem Biophys Res Comm"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ijc.10617","article-title":"Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.","volume":"101","author":"T Funasaka","year":"2002","journal-title":"Int J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1096\/fj.05-3699com","article-title":"Regulation of phosphoglucose isomerase\/autocrine motility factor expression by hypoxia.","volume":"19","author":"T Funasaka","year":"2005","journal-title":"FASEB J"},{"key":"ref30","first-page":"242","article-title":"Overexpression of the autocrine motility factor\/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.","volume":"63","author":"S Tsutsumi","year":"2003","journal-title":"Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"36362","DOI":"10.1074\/jbc.M706301200","article-title":"Down-regulation of Phosphoglucose Isomerase\/Autocrine Motility Factor Expression Sensitizes Human Fibrosarcoma Cells to Oxidative Stress Leading to Cellular Senescence.","volume":"282","author":"T Funasaka","year":"2007","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/07357909009012053","article-title":"The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer.","volume":"8","author":"M Baumann","year":"1990","journal-title":"Cancer Invest"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/1097-0142(195411)7:6<1200::AID-CNCR2820070612>3.0.CO;2-9","article-title":"Serum phosphohexose isomerase in cancer II. As an index of tumor growth in metastatic carcinoma of the breast.","volume":"7","author":"O Bodansky","year":"1954","journal-title":"Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000217737","article-title":"Serum phosphohexose isomerase activities in patients with colorectal cancer.","volume":"12","author":"X Filella","year":"1991","journal-title":"Tumor Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00043764-199009000-00017","article-title":"A new method for evaluation of urinary autocrine motility factor and tumor cell collagenase stimulating factor as markers for urinary tract cancers.","volume":"32","author":"R Guirguis","year":"1990","journal-title":"J Occup Med"},{"key":"ref36","first-page":"271","article-title":"Comparison between serum levels of carcinoembryonic antigen, sialic acid, and phosphohexose isomeras in lung cancer.","volume":"42","author":"PS Patel","year":"1995","journal-title":"Neoplasia"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/clinchem\/19.1.10","article-title":"Enzymes in cancer.","volume":"19","author":"MK Schwartz","year":"1973","journal-title":"Clin Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1091\/mbc.9.7.1773","article-title":"Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum.","volume":"9","author":"N Benlimame","year":"1998","journal-title":"Mol Biol Cell"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1074\/jbc.M111240200","article-title":"Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum.","volume":"277","author":"PU Le","year":"2002","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1242\/jcs.00327","article-title":"Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum.","volume":"116","author":"PU Le","year":"2003","journal-title":"J Cell Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"29305","DOI":"10.1074\/jbc.M704069200","article-title":"Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol-3-kinase-dependent in breast carcinoma cells.","volume":"282","author":"LD Kojic","year":"2007","journal-title":"J Biol Chem"},{"key":"ref42","first-page":"694","article-title":"Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.","volume":"61","author":"V Guillemard","year":"2001","journal-title":"Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1016\/S0021-9258(19)68639-4","article-title":"Taxol-induced polymerization of purified tubulin. Mechanism of action.","volume":"256","author":"N Kumar","year":"1981","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.2910400319","article-title":"Cell shape modulation alters glycosylation of a metastatic melanoma cell surface antigen.","volume":"40","author":"IR Nabi","year":"1987","journal-title":"Int J Cancer"},{"key":"ref45","first-page":"1258","article-title":"Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive variant.","volume":"48","author":"IR Nabi","year":"1988","journal-title":"Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/(SICI)1097-0215(19980330)76:1<120::AID-IJC19>3.0.CO;2-G","article-title":"Autocrine motility factor and the extracellular matrix. I. Coordinate regulation of melanoma cell adhesion, spreading and migration involves focal contact reorganization.","volume":"76","author":"S Silletti","year":"1998","journal-title":"Int J Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1097-0215(19980330)76:1<129::AID-IJC20>3.0.CO;2-6","article-title":"Autocrine motility factor and the extracellular matrix. II. Degradation or remodeling of substratum components directs the motile response of tumor cells.","volume":"76","author":"S Silletti","year":"1998","journal-title":"Int J Cancer"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/(SICI)1097-4547(20000601)60:5<602::AID-JNR5>3.0.CO;2-F","article-title":"Expression of the AMF\/neuroleukin receptor in developing and adult rat cerebellum.","volume":"60","author":"N Leclerc","year":"2000","journal-title":"J Neurosci Res"},{"key":"ref49","article-title":"Phosphorylated caveolin-1 regulates Rho\/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.","author":"B Joshi","year":"2008","journal-title":"Cancer Res"},{"key":"ref50","article-title":"Regulation of raft-dependent endocytosis.","author":"P Lajoie","year":"2007","journal-title":"J Cell Mol Med Submitted"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1568009043332989","article-title":"Novel approaches for targeted cancer therapy.","volume":"4","author":"V Guillemard","year":"2004","journal-title":"Curr Cancer Drug Targets"},{"key":"ref52","first-page":"409","article-title":"Identification of B16-F1 melanoma autocrine motility-like factor receptor.","volume":"50","author":"IR Nabi","year":"1990","journal-title":"Cancer Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000088070","article-title":"Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines.","volume":"69","author":"JL Yang","year":"2005","journal-title":"Oncology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0003597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T19:53:37Z","timestamp":1632081217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0003597"}},"subtitle":[],"editor":[{"given":"Joseph Alan","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,10,31]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2008,10,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0003597","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,31]]}}}